首页 > 最新文献

Paediatric Respiratory Reviews最新文献

英文 中文
A comparison of peak cough flow and peak expiratory flow in children with neuromuscular disorders 神经肌肉障碍儿童咳嗽峰值流速与呼气峰值流速的比较
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2024.04.001

Spirometry and peak cough flow testing (PCF) are commonly used in the respiratory assessment of children with a neuromuscular disorder (NMD). Testing uses two different machines, increases laboratory time, costs and resource utilisation. No studies have assessed the correlation between peak expiratory flow (PEF) obtained from spirometry and PCF in children with NMD using one device. An audit of children with a NMD managed at the Children’s Hospital at Westmead in 2022–2024 aged < 20 years who performed spirometry and PCF testing on the same device (Vyaire Body BoxTM, Ultrasonic flow meter-based, or Vyaire PneumotachographTM, Pneumotach flow meter-based; Germany) was conducted to assess the correlation between PCF and PEF. Fifty-one sets of testing were identified, and 40 subjects (9F) had reproducible testing and were included. Median (range) age was 14.95 (7.20–19.00) years. Median PEF (L/min) was 4.05 (1.22–10.26) and median PCF (L/min) was 4.29 (1.69–10.82). PEF and PCF had a strong Pearson’s correlation coefficient, (R = 0.97, p = 0.03). The coefficient of determination was 0.93. If laboratory resources permit, spirometry should be the test of choice for children with NMD. On average, spirometry required multiple practices to achieve reproducibility to meet ATS/ERS standards. PCF testing can be utilised for children where performing technically acceptable spirometry is not possible.

在对患有神经肌肉障碍(NMD)的儿童进行呼吸评估时,通常会使用肺活量和咳嗽峰流速测试(PCF)。测试使用两种不同的机器,增加了实验室时间、成本和资源利用率。目前还没有研究对使用一种设备对 NMD 儿童进行肺活量测定和 PCF 所获得的呼气峰值流速 (PEF) 之间的相关性进行评估。2022-2024 年,Westmead 儿童医院对年龄小于 20 岁、使用同一设备(德国 Vyaire Body Box,超声波流量计;或 Vyaire Pneumotachograph,气动流量计)进行肺活量和 PCF 测试的 NMD 患儿进行了审核,以评估 PCF 和 PEF 之间的相关性。共确定了 51 组测试,40 名受试者(9F)的测试结果具有可重复性,并被纳入其中。年龄中位数(范围)为 14.95(7.20-19.00)岁。中位 PEF(L/min)为 4.05(1.22-10.26),中位 PCF(L/min)为 4.29(1.69-10.82)。PEF 和 PCF 具有很强的皮尔逊相关系数(R = 0.97,P = 0.03)。判定系数为 0.93。如果实验室资源允许,应将肺活量测定作为 NMD 患儿的首选检测方法。平均而言,肺活量测定需要多次操作才能达到 ATS/ERS 标准的重现性要求。对于无法进行技术上可接受的肺活量测定的儿童,可使用 PCF 测试。
{"title":"A comparison of peak cough flow and peak expiratory flow in children with neuromuscular disorders","authors":"","doi":"10.1016/j.prrv.2024.04.001","DOIUrl":"10.1016/j.prrv.2024.04.001","url":null,"abstract":"<div><p><span><span>Spirometry and peak cough flow testing (PCF) are commonly used in the respiratory assessment of children with a </span>neuromuscular disorder (NMD). Testing uses two different machines, increases laboratory time, costs and resource utilisation. No studies have assessed the correlation between peak expiratory flow (PEF) obtained from spirometry and PCF in children with NMD using one device. An audit of children with a NMD managed at the Children’s Hospital at Westmead in 2022–2024 aged &lt; 20 years who performed spirometry and PCF testing on the same device (Vyaire Body Box</span><sup>TM</sup>, Ultrasonic flow meter-based, or Vyaire Pneumotachograph<sup>TM</sup>, Pneumotach flow meter-based; Germany) was conducted to assess the correlation between PCF and PEF. Fifty-one sets of testing were identified, and 40 subjects (9F) had reproducible testing and were included. Median (range) age was 14.95 (7.20–19.00) years. Median PEF (L/min) was 4.05 (1.22–10.26) and median PCF (L/min) was 4.29 (1.69–10.82). PEF and PCF had a strong Pearson’s correlation coefficient, (R = 0.97, p = 0.03). The coefficient of determination was 0.93. If laboratory resources permit, spirometry should be the test of choice for children with NMD. On average, spirometry required multiple practices to achieve reproducibility to meet ATS/ERS standards. PCF testing can be utilised for children where performing technically acceptable spirometry is not possible.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 26-31"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140577331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to deliver effective paediatric simulation based education 如何有效开展儿科模拟教学
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2024.05.001

Simulation based education (SBE) is an educational tool increasingly used in the approach to the initial and ongoing education of healthcare professionals. Like all education tools, SBE needs to be used appropriately to achieve the desired outcomes. Using Cognitive Load Theory (CLT) in the instructional design of simulations is essential to maximise participant learning by reducing extraneous load and optimising intrinsic load. Educators can modify task fidelity, task complexity and instructional support to optimise learning. Specific methodologies can be used in program design such as rapid cycle deliberate practice, round the table teaching, low dose high frequency and flipped classroom. Fidelity and authenticity are important factors to consider when choosing design elements to ensure learner engagement, but not to overwhelm cognitive load. An integral part of SBE is the feedback or debriefing component. Several evidence-based methodologies can be employed to facilitate post simulation learning, including Debriefing with Good Judgement and PEARLS. Educators also need to consider faculty education and development, such as the discovery, growth and maturity model.

模拟教育(SBE)是一种教育工具,越来越多地被用于医疗保健专业人员的初始教育和继续教育。与所有教育工具一样,SBE 也需要合理使用才能达到预期效果。在模拟教学设计中使用认知负荷理论(CLT)对于通过减少外在负荷和优化内在负荷最大限度地提高参与者的学习效果至关重要。教育者可以修改任务保真度、任务复杂度和教学支持,以优化学习效果。在项目设计中可以使用特定的方法,如快速循环刻意练习、圆桌教学、低剂量高频率和翻转课堂。在选择设计元素时,保真度和真实性是需要考虑的重要因素,以确保学习者的参与度,但又不会加重认知负担。反馈或汇报是 SBE 不可分割的一部分。可以采用几种基于证据的方法来促进模拟后学习,包括 "良好判断汇报 "和 "PEARLS"。教育者还需要考虑教师的教育和发展,如发现、成长和成熟模型。
{"title":"How to deliver effective paediatric simulation based education","authors":"","doi":"10.1016/j.prrv.2024.05.001","DOIUrl":"10.1016/j.prrv.2024.05.001","url":null,"abstract":"<div><p>Simulation based education (SBE) is an educational tool increasingly used in the approach to the initial and ongoing education of healthcare professionals. Like all education tools, SBE needs to be used appropriately to achieve the desired outcomes. Using Cognitive Load Theory (CLT) in the instructional design of simulations is essential to maximise participant learning by reducing extraneous load and optimising intrinsic load. Educators can modify task fidelity, task complexity and instructional support to optimise learning. Specific methodologies can be used in program design such as rapid cycle deliberate practice, round the table teaching, low dose high frequency and flipped classroom. Fidelity and authenticity are important factors to consider when choosing design elements to ensure learner engagement, but not to overwhelm cognitive load. An integral part of SBE is the feedback or debriefing component. Several evidence-based methodologies can be employed to facilitate post simulation learning, including Debriefing with Good Judgement and PEARLS. Educators also need to consider faculty education and development, such as the discovery, growth and maturity model.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 10-18"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1526054224000459/pdfft?md5=383550ee0f562b49b2974a43484a2a11&pid=1-s2.0-S1526054224000459-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141042823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“Antibiotic hypersensitivity reactions in Cystic Fibrosis: A thorough inspection on a stumbling block in patient care” "囊性纤维化中的抗生素超敏反应:彻底检查患者护理中的绊脚石"
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2024.01.004

One hurdle in the management of CF, a disease characterized by progressive endobronchial infection, is the presence of hypersensitivity reactions to antimicrobials due to prolonged and repetitive treatment courses. The aim of this review is to compile existing data and provide insight to medical professionals on a long-debated topic for optimum patient care. Clinical studies were inducted from the last 15 years and filtered based on their relativity to drug hypersensitivity reactions (DHRs), antibiotics and CF. After completing the selection process, 10 clinical studies were thoroughly examined. The most frequent antibiotic group related to DHRs were beta-lactams. Frequency of the most common overall type of reaction (immediate or nonimmediate) differed among clinical studies. Although severe reactions seem rare comparatively, they do occur during and even after completion of treatment regimens. The prevalence of true drug allergies should be confirmed using a variety of tests available, however, should not be confused with overall DHR rates. Genetic mutations, gender and lifetime antibiotic dose were not related with an increased risk for DHR development. On the contrary, the most important factor according to most studies was the cumulative antimicrobial dose in a given period of time, especially when delivered parenterally. DHRs are an indisputable problem in the management of CF patients. Understanding possible risk factors and increased awareness is vital in both hospital and outpatient settings as early detection can decrease the severity of the reactions.

CF 是一种以进行性支气管内感染为特征的疾病,其治疗过程中的一个障碍是由于长期和重复的治疗过程而导致的对抗菌药物的超敏反应。本综述旨在汇编现有数据,并就这一长期争论的话题为医疗专业人员提供见解,以优化患者护理。本综述收集了过去 15 年中的临床研究,并根据其与药物超敏反应(DHR)、抗生素和 CF 的相关性进行了筛选。在完成筛选过程后,对 10 项临床研究进行了全面检查。与药物过敏反应相关的最常见抗生素组别是β-内酰胺类。各临床研究中最常见的总体反应类型(即刻反应或非即刻反应)的发生率各不相同。虽然严重的反应似乎比较罕见,但在治疗过程中甚至在治疗结束后确实会发生。真正的药物过敏发生率应使用现有的各种检测方法进行确认,但不应与总体 DHR 发生率相混淆。基因突变、性别和终生抗生素剂量与 DHR 发生风险的增加无关。相反,根据大多数研究,最重要的因素是特定时间内累积的抗菌剂剂量,尤其是经肠外给药时。DHR 是 CF 患者管理中一个无可争议的问题。在医院和门诊环境中,了解可能的风险因素并提高意识至关重要,因为早期发现可降低反应的严重程度。
{"title":"“Antibiotic hypersensitivity reactions in Cystic Fibrosis: A thorough inspection on a stumbling block in patient care”","authors":"","doi":"10.1016/j.prrv.2024.01.004","DOIUrl":"10.1016/j.prrv.2024.01.004","url":null,"abstract":"<div><p>One hurdle in the management of CF<span>, a disease characterized by progressive endobronchial infection, is the presence of hypersensitivity reactions to antimicrobials due to prolonged and repetitive treatment courses. The aim of this review is to compile existing data and provide insight to medical professionals on a long-debated topic for optimum patient care. Clinical studies were inducted from the last 15 years and filtered based on their relativity to drug hypersensitivity<span><span> reactions (DHRs), antibiotics and CF. After completing the selection process, 10 clinical studies were thoroughly examined. The most frequent antibiotic<span> group related to DHRs were beta-lactams. Frequency of the most common overall type of reaction (immediate or nonimmediate) differed among clinical studies. Although severe reactions seem rare comparatively, they do occur during and even after completion of treatment regimens. The prevalence of true drug allergies should be confirmed using a variety of tests available, however, should not be confused with overall DHR rates. </span></span>Genetic mutations, gender and lifetime antibiotic dose were not related with an increased risk for DHR development. On the contrary, the most important factor according to most studies was the cumulative antimicrobial dose in a given period of time, especially when delivered parenterally. DHRs are an indisputable problem in the management of CF patients. Understanding possible risk factors and increased awareness is vital in both hospital and outpatient settings as early detection can decrease the severity of the reactions.</span></span></p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 56-65"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139815878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of maternal asthma on the fetal lung: Outcomes, mechanisms and interventions 母体哮喘对胎儿肺部的影响:结果、机制和干预措施
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2023.12.004

Maternal asthma affects up to 17% of pregnancies and is associated with adverse infant, childhood, and adult respiratory outcomes, including increased risks of neonatal respiratory distress syndrome, childhood wheeze and asthma. In addition to genetics, these poor outcomes are likely due to the mediating influence of maternal asthma on the in-utero environment, altering fetal lung and immune development and predisposing the offspring to later lung disease. Maternal asthma may impair glucocorticoid signalling in the fetus, a process critical for lung maturation, and increase fetal exposure to proinflammatory cytokines. Therefore, interventions to control maternal asthma, increase glucocorticoid signalling in the fetal lung, or Vitamin A, C, and D supplementation to improve alveologenesis and surfactant production may be beneficial for later lung function. This review highlights potential mechanisms underlying maternal asthma and offspring respiratory morbidities and describes how pregnancy interventions can promote optimal fetal lung development in babies of asthmatic mothers.

产妇哮喘影响到高达 17% 的孕妇,并与婴儿、儿童和成人呼吸系统的不良后果有关,包括新生儿呼吸窘迫综合征、儿童喘息和哮喘的风险增加。除遗传因素外,这些不良后果很可能是由于母体哮喘对子宫内环境的介导影响,改变了胎儿肺部和免疫系统的发育,使后代日后易患肺部疾病。母体哮喘可能会损害胎儿体内糖皮质激素信号的传递(这是肺成熟的关键过程),并增加胎儿暴露于促炎细胞因子的机会。因此,采取干预措施控制母体哮喘、增加胎儿肺中的糖皮质激素信号,或补充维生素 A、C 和 D 以改善肺泡生成和表面活性物质的产生,可能对日后的肺功能有益。本综述强调了母体哮喘和后代呼吸系统疾病的潜在机制,并介绍了妊娠干预措施如何促进哮喘母亲的胎儿肺部发育达到最佳状态。
{"title":"The impact of maternal asthma on the fetal lung: Outcomes, mechanisms and interventions","authors":"","doi":"10.1016/j.prrv.2023.12.004","DOIUrl":"10.1016/j.prrv.2023.12.004","url":null,"abstract":"<div><p>Maternal asthma affects up to 17% of pregnancies and is associated with adverse infant, childhood, and adult respiratory outcomes, including increased risks of neonatal respiratory distress syndrome, childhood wheeze and asthma. In addition to genetics, these poor outcomes are likely due to the mediating influence of maternal asthma on the <em>in-utero</em> environment, altering fetal lung and immune development and predisposing the offspring to later lung disease. Maternal asthma may impair glucocorticoid signalling in the fetus, a process critical for lung maturation, and increase fetal exposure to proinflammatory cytokines. Therefore, interventions to control maternal asthma, increase glucocorticoid signalling in the fetal lung, or Vitamin A, C, and D supplementation to improve alveologenesis and surfactant production may be beneficial for later lung function. This review highlights potential mechanisms underlying maternal asthma and offspring respiratory morbidities and describes how pregnancy interventions can promote optimal fetal lung development in babies of asthmatic mothers.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 38-45"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1526054223000866/pdfft?md5=1add1cb172faa202e6b911055c66cf87&pid=1-s2.0-S1526054223000866-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139020502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review 预测 CRMS/CFSPID 受试者发展为囊性纤维化的生化和遗传工具:系统综述
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-09-01 DOI: 10.1016/j.prrv.2024.01.001

Objectives

Aim of this study was to identify risk factors for a progression to cystic fibrosis (CF) in individuals detected as CF Screening Positive, Inconclusive Diagnosis (CFSPID).

Methods

This is a systematic review through literature databases (2015–2023). Blood immunoreactive trypsinogen (b-IRT) values, CFTR genotype, sweat chloride (SC) values, isolation of Pseudomonas aeruginosa (Pa) from respiratory samples, Lung Clearance Index (LCI) values in CFSPIDs who converted to CF (CFSPID > CF) and age at CF transition were assessed.

Results

Percentage of CFSPID > CF varies from 5.3 % to 44 %. Presence of one CF-causing CFTR variant in trans with a variant with variable clinical consequences (VVCC), an initial SC ≥ 40 mmol/L, an increase of SC > 2.5 mmol/L/year and recurrent isolation of pseudomonas aeruginosa (Pa) from airway samples could allow identification of subjects at risk of progression to CF.

Conclusions

CFSPIDs with CF causing variant/VVCC genotype and first SC in the higher borderline range may require more frequent and prolonged clinical follow-up.

本研究旨在确定被检测为 CF 筛查阳性、诊断不确定(CFSPID)的个体发展为囊性纤维化(CF)的风险因素。评估了血液免疫反应性胰蛋白酶原(b-IRT)值、CFTR基因型、汗液氯化物(SC)值、从呼吸道样本中分离出的铜绿假单胞菌(Pa)、转为CF(CFSPID>CF)的CFSPID的肺通畅指数(LCI)值和CF转归年龄。结果CFSPID>CF的比例从5.3%到44%不等。结果CFSPID>CF的比例从5.3%到44%不等。在与临床后果可变的变体(VVCC)、初始SC≥40 mmol/L、SC>2.5 mmol/L/年的增长以及从气道样本中反复分离出铜绿假单胞菌(Pa)的反式中存在一个CF致病CFTR变体,可以识别有进展为CF风险的受试者。
{"title":"Biochemical and genetic tools to predict the progression to Cystic Fibrosis in CRMS/CFSPID subjects: A systematic review","authors":"","doi":"10.1016/j.prrv.2024.01.001","DOIUrl":"10.1016/j.prrv.2024.01.001","url":null,"abstract":"<div><h3>Objectives</h3><p>Aim of this study was to identify risk factors for a progression to cystic fibrosis (CF) in individuals detected as CF Screening Positive, Inconclusive Diagnosis (CFSPID).</p></div><div><h3>Methods</h3><p>This is a systematic review through literature databases (2015–2023). Blood immunoreactive trypsinogen (b-IRT) values, <em>CFTR</em> genotype, sweat chloride (SC) values, isolation of <em>Pseudomonas aeruginosa</em> (Pa) from respiratory samples, Lung Clearance Index (LCI) values in CFSPIDs who converted to CF (CFSPID &gt; CF) and age at CF transition were assessed.</p></div><div><h3>Results</h3><p>Percentage of CFSPID &gt; CF varies from 5.3 % to 44 %. Presence of one CF-causing <em>CFTR</em> variant in trans with a variant with variable clinical consequences (VVCC), an initial SC ≥ 40 mmol/L, an increase of SC &gt; 2.5 mmol/L/year and recurrent isolation of pseudomonas aeruginosa (Pa) from airway samples could allow identification of subjects at risk of progression to CF.</p></div><div><h3>Conclusions</h3><p>CFSPIDs with CF causing variant/VVCC genotype and first SC in the higher borderline range may require more frequent and prolonged clinical follow-up.</p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"51 ","pages":"Pages 46-55"},"PeriodicalIF":4.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1526054224000022/pdfft?md5=3444d1ed965aa205ceb61fe210d668de&pid=1-s2.0-S1526054224000022-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139498422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the complexity of cystic fibrosis (CF) and psychosocial wellbeing in the 2020s: Current and future challenges 探讨 2020 年代囊性纤维化(CF)和社会心理健康的复杂性:当前和未来的挑战
IF 5.8 3区 医学 Q1 PEDIATRICS Pub Date : 2024-08-16 DOI: 10.1016/j.prrv.2024.08.001
Rebecca Dobra, Sarah Carroll, Jane C. Davies, Fiona Dowdall, Alistair Duff, Anna Elderton, Anna M. Georgiopoulos, Rachel Massey-Chase, Paul McNally, Michèle Puckey, Susan Madge
Cystic fibrosis (CF) is traditionally associated with considerable and progressive multisystem pathology, onerous treatment burden, complex psychosocial challenges, and reduced life-expectancy .This decade has seen transformative change in management for many, but not all, people with CF. The most notable change comes from Cystic Fibrosis Transmembrane Receptor (CFTR) modulators, which bring significant benefits for people who are eligible for, and able to access, them . However alongside, or perhaps because of, this exciting progress, the past few years have also brought important novel challenges to the psychosocial wellbeing of people with CF.
囊性纤维化(CF)历来与严重的进行性多系统病变、繁重的治疗负担、复杂的社会心理挑战和预期寿命缩短有关。最显著的变化来自囊性纤维化跨膜受体(CFTR)调节剂,它为有资格和有能力使用这些药物的患者带来了巨大的益处。然而,在取得这些令人振奋的进展的同时,或者说正因为取得了这些进展,过去几年也给 CF 患者的社会心理健康带来了新的重大挑战。
{"title":"Exploring the complexity of cystic fibrosis (CF) and psychosocial wellbeing in the 2020s: Current and future challenges","authors":"Rebecca Dobra, Sarah Carroll, Jane C. Davies, Fiona Dowdall, Alistair Duff, Anna Elderton, Anna M. Georgiopoulos, Rachel Massey-Chase, Paul McNally, Michèle Puckey, Susan Madge","doi":"10.1016/j.prrv.2024.08.001","DOIUrl":"https://doi.org/10.1016/j.prrv.2024.08.001","url":null,"abstract":"Cystic fibrosis (CF) is traditionally associated with considerable and progressive multisystem pathology, onerous treatment burden, complex psychosocial challenges, and reduced life-expectancy .This decade has seen transformative change in management for many, but not all, people with CF. The most notable change comes from Cystic Fibrosis Transmembrane Receptor (CFTR) modulators, which bring significant benefits for people who are eligible for, and able to access, them . However alongside, or perhaps because of, this exciting progress, the past few years have also brought important novel challenges to the psychosocial wellbeing of people with CF.","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"62 1","pages":""},"PeriodicalIF":5.8,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142224056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hereditary haemorrhagic telangiectasia: A primer for the paediatrician. 遗传性出血性毛细血管扩张症:儿科医生入门指南。
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-08-02 DOI: 10.1016/j.prrv.2024.07.003
Yoshua Selvadurai, Emily R Le Fevre, Jonathan Mervis, Dominic A Fitzgerald

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant condition characterised by small telangiectasias and larger multisystem arteriovenous malformations (AVMs). Common sites of AVMs include in the nose, lungs, brain and liver. These lesions are prone to rupture, leading to complications including recurrent epistaxis and significant haemorrhage. Pulmonary hypertension (PH) can also occur. This review presents an update on the genetics, clinical manifestations, management options, and screening recommendations for children with HHT.

遗传性出血性毛细血管扩张症(HHT)是一种常染色体显性遗传病,其特征是小的毛细血管扩张和大的多系统动静脉畸形(AVM)。动静脉畸形的常见部位包括鼻、肺、脑和肝。这些病变容易破裂,导致包括反复鼻衄和大出血在内的并发症。肺动脉高压(PH)也可能发生。本综述介绍了遗传学、临床表现、治疗方案和 HHT 儿童筛查建议的最新进展。
{"title":"Hereditary haemorrhagic telangiectasia: A primer for the paediatrician.","authors":"Yoshua Selvadurai, Emily R Le Fevre, Jonathan Mervis, Dominic A Fitzgerald","doi":"10.1016/j.prrv.2024.07.003","DOIUrl":"https://doi.org/10.1016/j.prrv.2024.07.003","url":null,"abstract":"<p><p>Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant condition characterised by small telangiectasias and larger multisystem arteriovenous malformations (AVMs). Common sites of AVMs include in the nose, lungs, brain and liver. These lesions are prone to rupture, leading to complications including recurrent epistaxis and significant haemorrhage. Pulmonary hypertension (PH) can also occur. This review presents an update on the genetics, clinical manifestations, management options, and screening recommendations for children with HHT.</p>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142110526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Climate change and children's respiratory health. 气候变化与儿童呼吸道健康。
IF 4.7 3区 医学 Q1 PEDIATRICS Pub Date : 2024-07-29 DOI: 10.1016/j.prrv.2024.07.002
Camille Bignier, Lucile Havet, Margot Brisoux, Céline Omeiche, Swati Misra, Apolline Gonsard, David Drummond

Climate change has significant consequences for children's respiratory health. Rising temperatures and extreme weather events increase children's exposure to allergens, mould, and air pollutants. Children are particularly vulnerable to these airborne particles due to their higher ventilation per unit of body weight, more frequent mouth breathing, and outdoor activities. Children with asthma and cystic fibrosis are at particularly high risk, with increased risks of exacerbation, but the effects of climate change could also be observed in the general population, with a risk of impaired lung development and growth. Mitigation measures, including reducing greenhouse gas emissions by healthcare professionals and healthcare systems, and adaptation measures, such as limiting outdoor activities during pollution peaks, are essential to preserve children's respiratory health. The mobilisation of society as a whole, including paediatricians, is crucial to limit the impact of climate change on children's respiratory health.

气候变化对儿童的呼吸系统健康有重大影响。气温升高和极端天气事件增加了儿童接触过敏原、霉菌和空气污染物的机会。由于儿童的单位体重通气量较高、口呼吸较频繁以及户外活动较多,他们特别容易受到这些空气微粒的影响。患有哮喘和囊性纤维化的儿童面临的风险尤其高,病情恶化的风险也会增加,但气候变化的影响也可能出现在普通人群中,他们的肺部发育和成长可能会受损。减缓措施(包括医疗保健专业人员和医疗保健系统减少温室气体排放)和适应措施(如在污染高峰期限制户外活动)对于保护儿童的呼吸系统健康至关重要。动员包括儿科医生在内的全社会,对于限制气候变化对儿童呼吸健康的影响至关重要。
{"title":"Climate change and children's respiratory health.","authors":"Camille Bignier, Lucile Havet, Margot Brisoux, Céline Omeiche, Swati Misra, Apolline Gonsard, David Drummond","doi":"10.1016/j.prrv.2024.07.002","DOIUrl":"https://doi.org/10.1016/j.prrv.2024.07.002","url":null,"abstract":"<p><p>Climate change has significant consequences for children's respiratory health. Rising temperatures and extreme weather events increase children's exposure to allergens, mould, and air pollutants. Children are particularly vulnerable to these airborne particles due to their higher ventilation per unit of body weight, more frequent mouth breathing, and outdoor activities. Children with asthma and cystic fibrosis are at particularly high risk, with increased risks of exacerbation, but the effects of climate change could also be observed in the general population, with a risk of impaired lung development and growth. Mitigation measures, including reducing greenhouse gas emissions by healthcare professionals and healthcare systems, and adaptation measures, such as limiting outdoor activities during pollution peaks, are essential to preserve children's respiratory health. The mobilisation of society as a whole, including paediatricians, is crucial to limit the impact of climate change on children's respiratory health.</p>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141897945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paediatric melioidosis 儿科类鼻疽
IF 5.8 3区 医学 Q1 PEDIATRICS Pub Date : 2024-06-01 DOI: 10.1016/j.prrv.2023.11.002
Olivia Jarrett , Soputhirith Seng , Dominic A. Fitzgerald

Melioidosis is a tropical infectious disease caused by the saprophytic gram-negative bacterium Burkholderia pseudomallei. Despite the infection being endemic in southeast Asia and northern Australia, the broad clinical presentations and diagnostic difficulties limit its early detection, particularly in children. Melioidosis more commonly affects the immunocompromised and adults. Melioidosis is increasingly being diagnosed around the world and whole-genome sequencing indicates that these cases are not linked with travel to endemic areas. Research has concentrated on the adult population with limited experience reported in the care of this uncommon, but potentially fatal condition in children presenting with bacteraemia and pneumonia.

类鼻疽病是一种热带传染病,由腐生革兰氏阴性菌伯克氏菌引起。尽管这种感染在东南亚和澳大利亚北部流行,但广泛的临床表现和诊断困难限制了其早期发现,特别是在儿童中。类鼻疽多见于免疫功能低下者和成人。世界各地越来越多地诊断出类鼻疽,全基因组测序表明,这些病例与前往流行地区的旅行无关。研究主要集中在成人人群,据报道,在以菌血症和肺炎为症状的儿童中,这种罕见但可能致命的疾病的护理经验有限。
{"title":"Paediatric melioidosis","authors":"Olivia Jarrett ,&nbsp;Soputhirith Seng ,&nbsp;Dominic A. Fitzgerald","doi":"10.1016/j.prrv.2023.11.002","DOIUrl":"10.1016/j.prrv.2023.11.002","url":null,"abstract":"<div><p>Melioidosis is a tropical infectious disease caused by the saprophytic gram-negative bacterium <span><em>Burkholderia pseudomallei</em></span><span>. Despite the infection being endemic in southeast Asia and northern Australia, the broad clinical presentations and diagnostic difficulties limit its early detection, particularly in children. Melioidosis more commonly affects the immunocompromised and adults. Melioidosis is increasingly being diagnosed around the world and whole-genome sequencing indicates that these cases are not linked with travel to endemic areas. Research has concentrated on the adult population with limited experience reported in the care of this uncommon, but potentially fatal condition in children presenting with bacteraemia and pneumonia.</span></p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"50 ","pages":"Pages 31-37"},"PeriodicalIF":5.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138516921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Racial and skin color mediated disparities in pulse oximetry in infants and young children 婴幼儿脉搏血氧仪的种族和肤色差异
IF 5.8 3区 医学 Q1 PEDIATRICS Pub Date : 2024-06-01 DOI: 10.1016/j.prrv.2023.12.006
Megha Sharma , Andrew W Brown , Nicholas M. Powell , Narasimhan Rajaram , Lauren Tong , Peter M. Mourani , Mario Schootman

Race-based and skin pigmentation-related inaccuracies in pulse oximetry have recently been highlighted in several large electronic health record-based retrospective cohort studies across diverse patient populations and healthcare settings. Overestimation of oxygen saturation by pulse oximeters, particularly in hypoxic states, is disparately higher in Black compared to other racial groups. Compared to adult literature, pediatric studies are relatively few and mostly reliant on birth certificates or maternal race-based classification of comparison groups. Neonates, infants, and young children are particularly susceptible to the adverse life-long consequences of hypoxia and hyperoxia. Successful neonatal resuscitation, precise monitoring of preterm and term neonates with predominantly lung pathology, screening for congenital heart defects, and critical decisions on home oxygen, ventilator support and medication therapies, are only a few examples of situations that are highly reliant on the accuracy of pulse oximetry. Undetected hypoxia, especially if systematically different in certain racial groups may delay appropriate therapies and may further perpetuate health care disparities. The role of biological factors that may differ between racial groups, particularly skin pigmentation that may contribute to biased pulse oximeter readings needs further evaluation. Developmental and maturational changes in skin physiology and pigmentation, and its interaction with the operating principles of pulse oximetry need further study. Importantly, clinicians should recognize the limitations of pulse oximetry and use additional objective measures of oxygenation (like co-oximetry measured arterial oxygen saturation) where hypoxia is a concern.

最近,几项基于电子健康记录的大型回顾性队列研究强调了脉搏血氧仪中与种族和皮肤色素有关的不准确性,这些研究涉及不同的患者群体和医疗机构。脉搏血氧仪高估了血氧饱和度,尤其是在缺氧状态下,黑人的血氧饱和度高于其他种族群体。与成人文献相比,儿科研究相对较少,且大多依赖于出生证明或基于母亲种族划分的对比组。新生儿、婴儿和幼儿特别容易受到缺氧和高氧所带来的终生不良后果的影响。成功的新生儿复苏、对以肺部病变为主的早产儿和足月新生儿的精确监测、先天性心脏缺陷筛查,以及家庭供氧、呼吸机支持和药物治疗的关键决策,这些只是高度依赖脉搏血氧仪准确性的几个例子。未被发现的缺氧,尤其是在某些种族群体中存在系统性差异的情况下,可能会延误适当的治疗,并可能进一步延续医疗保健差异。需要进一步评估不同种族群体之间可能存在差异的生物因素的作用,特别是可能导致脉搏血氧仪读数偏差的皮肤色素沉着。皮肤生理和色素的发育和成熟变化及其与脉搏血氧仪操作原理的相互作用也需要进一步研究。重要的是,临床医生应认识到脉搏血氧仪的局限性,并在缺氧问题令人担忧时使用其他客观的氧饱和度测量方法(如协同氧饱和度测量动脉血氧饱和度)。
{"title":"Racial and skin color mediated disparities in pulse oximetry in infants and young children","authors":"Megha Sharma ,&nbsp;Andrew W Brown ,&nbsp;Nicholas M. Powell ,&nbsp;Narasimhan Rajaram ,&nbsp;Lauren Tong ,&nbsp;Peter M. Mourani ,&nbsp;Mario Schootman","doi":"10.1016/j.prrv.2023.12.006","DOIUrl":"10.1016/j.prrv.2023.12.006","url":null,"abstract":"<div><p><span><span><span>Race-based and skin pigmentation-related inaccuracies in pulse oximetry have recently been highlighted in several large electronic health record-based </span>retrospective cohort studies across diverse patient populations and healthcare settings. Overestimation of oxygen saturation by pulse oximeters, particularly in hypoxic states, is disparately higher in Black compared to other racial groups. Compared to adult literature, pediatric studies are relatively few and mostly reliant on birth certificates or maternal race-based classification of comparison groups. Neonates, infants, and </span>young children<span><span> are particularly susceptible to the adverse life-long consequences of hypoxia and </span>hyperoxia<span>. Successful neonatal resuscitation, precise monitoring of preterm and term neonates with predominantly lung pathology, screening for </span></span></span>congenital heart defects<span><span>, and critical decisions on home oxygen, ventilator support and medication therapies, are only a few examples of situations that are highly reliant on the accuracy of pulse oximetry. Undetected hypoxia, especially if systematically different in certain racial groups may delay appropriate therapies and may further perpetuate </span>health care disparities<span>. The role of biological factors that may differ between racial groups, particularly skin pigmentation that may contribute to biased pulse oximeter readings needs further evaluation. Developmental and maturational changes in skin physiology and pigmentation, and its interaction with the operating principles of pulse oximetry need further study. Importantly, clinicians should recognize the limitations of pulse oximetry and use additional objective measures of oxygenation (like co-oximetry measured arterial oxygen saturation) where hypoxia is a concern.</span></span></p></div>","PeriodicalId":19658,"journal":{"name":"Paediatric Respiratory Reviews","volume":"50 ","pages":"Pages 62-72"},"PeriodicalIF":5.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139376187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Paediatric Respiratory Reviews
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1